Perspective Therapeutics, Inc. (CATX) vs CapsoVision, Inc. (CV)
Perspective Therapeutics, Inc. and CapsoVision, Inc. are both Medical Devices companies. CapsoVision, Inc. is the larger, with a market value of $328.3M against $285.4M — 1.2× the size. Perspective Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; CapsoVision, Inc. trades at 2.1×. CapsoVision, Inc. grew revenue faster over the last twelve months: 16.7% against −66.9%. CapsoVision, Inc. has the higher net margin (−214.7% vs −28,468.0%) and the lower return on invested capital (−460.9% vs −88.4%). Across the 17 metrics below, CapsoVision, Inc. leads on 12 and Perspective Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | CATX | CV | Medical Devices median |
|---|---|---|---|
| Gross margin | 100.00% | 50.88% | 56.01% |
| Operating margin | (30,619.07%) | (217.09%) | (15.03%) |
| Net margin | (28,467.97%) | (214.74%) | (20.40%) |
| Free cash flow margin | (29,630.07%) | (200.77%) | (7.24%) |
| Return on equity | (39.50%) | 47.42% | (15.32%) |
| Return on assets | (33.14%) | (212.19%) | (19.72%) |
| Return on invested capital | (88.41%) | (460.93%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack